SEATTLE GENETICS, INC.

Healthcare 📍 Bothell, United States 👥 501-1000 employees 💰 $164.0M raised 📅 Founded 1998 🏷 SGEN

Seattle Genetics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in pivotal trial for patients with relapsed or refractory hodgkin lymphoma. The company's other

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

501-1000

Public · SGEN

Listed

Founded

1998

Cloud

Unknown

CDN

Cloudflare

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Behind Cloudflare — actual host undetectable

Workspace	🔒 Subscribers only
CDN	Cloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$3M – $7M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	Drupal
Frontend Stack	🔒 Subscribers only

Detected from SEATTLE GENETICS, INC.'s public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Peloton Interactive

1001-5000 ☁️ Vercel

1001-5000 ☁️ Unknown

1001-5000 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction